Actinium Pharmaceuticals, Inc. (ATNM) vs Seres Therapeutics, Inc. (MCRB)

Actinium Pharmaceuticals, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Seres Therapeutics, Inc. are of similar size ($37.4M and $36.0M). Seres Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.3×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against −98.5%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs −1,192.9%) and the higher return on invested capital (0.00% vs −277.3%). Across the 16 metrics below, Actinium Pharmaceuticals, Inc. leads on 13 and Seres Therapeutics, Inc. on 3.